Unexplained weight loss (UWL), defined as a loss of more than 5% of body weight over 6-12 months, can be an indicator of a serious underlying condition. For clinicians, diagnosing the cause can be challenging due to the wide range of potential etiologies.
A comprehensive history and physical examination are paramount in the evaluation of UWL. This should include detailed dietary history, lifestyle factors, medication use, and psychosocial history. The physical examination should focus on signs of malnutrition, systemic diseases, and malignancy.
While there is no standard diagnostic algorithm for UWL, initial laboratory tests should include complete blood count, metabolic panel, thyroid function tests, HIV test, and tumor markers. Imaging studies, such as CT scan or PET, may be required based on specific clinical suspicion.
Given the multifactorial nature of UWL, a multidisciplinary approach involving primary care physicians, gastroenterologists, endocrinologists, psychiatrists, and dieticians can be beneficial in reaching a definitive diagnosis.
While common causes such as malignancies, gastrointestinal disorders, and psychiatric conditions account for most cases of UWL, rare causes like Addison's disease, celiac disease, and parasitic infections should also be considered in the differential diagnosis.
Diagnosing UWL requires a systematic and comprehensive approach. While the diagnostic process can be complex and time-consuming, it is crucial to identify and address the underlying cause promptly to prevent further health deterioration. Continued research and development of more targeted diagnostic tools will aid in the timely diagnosis and management of patients presenting with UWL.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation